CanSense, a Swansea company which has developed a blood test that aims to save lives by diagnosing bowel cancer at an early stage – has raised £1.5m from Mercia, the Development Bank of Wales and liquid biopsy company Nonacus. CanSense’s test, which combines laser spectroscopy with artificial intelligence, is faster, less expensive and less invasive … Continue reading Bowel cancer startup raises £1.5m in investment